This page in English
Laddar profil information

Om mig

Jag är för närvarande ST-läkare på PO Hematologi vid Karolinska Universitetssjukhuset samt post-doc i gruppen för cancer epidemiologi på KEP. För mer information om min forskning, se den engelska versionen av den här sidan.

Publikationer

Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study
Wästerlid T, Mohammadi M, Smedby Ke, Glimelius I, Jerkeman M, Bottai M, et al
Journal of internal medicine 2018;():-

Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study
Wästerlid T, Biccler Jl, Brown Pn, Bøgsted M, Enblad G, Mészáros Jørgensen J, et al
Annals of oncology : official journal of the European Society for Medical Oncology 2018;29(8):1882-1883

Frequency and clinical implications of SOX11 expression in Burkitt lymphoma
Wasterlid T, Nordstrom L, Freiburghaus C, Pedersen M, Norgaard P, Gang Ao, et al
LEUKEMIA & LYMPHOMA 2017;58(7):1760-1763

Impact on survival of addition of etoposide to primary chemotherapy in diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study
Wasterlid T, Hartman L, Szekely E, Jerkeman M
HEMATOLOGICAL ONCOLOGY 2017;35(2):151-157

Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group
Wasterlid T, Brown Pn, Hagberg O, Hagberg H, Pedersen Lm, D'amore F, et al
ANNALS OF ONCOLOGY 2013;24(7):1879-86

Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study
Wasterlid T, Jonsson B, Hagberg H, Jerkeman M
LEUKEMIA & LYMPHOMA 2011;52(11):2090-6